Efficacy and Safety of Very Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Background and Objective: Dual antiplatelet therapy (DAPT) is the basis for preventing ischemic events after percutaneous coronary intervention (PCI), and DAPT for 12 months has been the standard strategy recommended by the guidelines. However, patients with acute coronary syndrome (ACS) have a high...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Peng-Yu, Shang, Yao-Sheng, Bai, Nan, Ma, Ying, Niu, Ying, Wang, Zhi-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452852/
https://www.ncbi.nlm.nih.gov/pubmed/34557526
http://dx.doi.org/10.3389/fcvm.2021.660360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452852/
https://www.ncbi.nlm.nih.gov/pubmed/34557526
http://dx.doi.org/10.3389/fcvm.2021.660360

Ejemplares similares